SC 13G/A: Autolus Therapeutics plc
Ticker: AUTL · Form: SC 13G/A · Filed: 2024-02-14T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Autolus Therapeutics plc.
Risk Assessment
Risk Level: low
From the Filing
0001172661-24-000912.txt : 20240214 0001172661-24-000912.hdr.sgml : 20240214 20240214083720 ACCESSION NUMBER: 0001172661-24-000912 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Autolus Therapeutics plc CENTRAL INDEX KEY: 0001730463 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-90550 FILM NUMBER: 24632616 BUSINESS ADDRESS: STREET 1: THE MEDIAWORKS STREET 2: 191 WOOD LANE CITY: LONDON STATE: X0 ZIP: W12 7FP BUSINESS PHONE: 44 20 3829 6230 MAIL ADDRESS: STREET 1: THE MEDIAWORKS STREET 2: 191 WOOD LANE CITY: LONDON STATE: X0 ZIP: W12 7FP FORMER COMPANY: FORMER CONFORMED NAME: Autolus Therapeutics Ltd DATE OF NAME CHANGE: 20180205 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Deep Track Capital, LP CENTRAL INDEX KEY: 0001856083 ORGANIZATION NAME: IRS NUMBER: 853360885 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 200 GREENWICH AVENUE STREET 2: 3RD FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 2034090812 MAIL ADDRESS: STREET 1: 200 GREENWICH AVENUE STREET 2: 3RD FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 SC 13G/A 1 deeptrack-autl123123a2.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Autolus Therapeutics PLC (Name of Issuer) American Depositary Shares, each representing one ordinary share, nominal value $0.000042 per share (Title of Class of Securities) 05280R100 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: o 	Rule 13d-1(b) x 	Rule 13d-1(c) o 	Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No.  05280R100   SCHEDULE 13G/A Page 2 of 9 Pages           1 NAME OF REPORTING PERSONS Deep Track Capital, LP 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) x   3 SEC USE ONLY     4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER   0 6 SHARED VOTING POWER   11,869,297 7 SOLE DISPOSITIVE POWER   0 8 SHARED DISPOSITIVE POWER   11,869,297 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   11,869,297 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES     o 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)   6.82% 12 TYPE OF REPORTING PERSON   IA, OO CUSIP No.  05280R100   SCHEDULE 13G/A Page 3 of 9 Pages           1 NAME OF REPORTING PERSONS Deep Track Biotechnology Master Fund, Ltd. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) x   3 SEC USE ONLY     4 CITIZENSHIP OR PLACE OF ORGANIZATION   Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER   0 6 SHARED VOTING POWER   11,869,297 7 SOLE DISPOSITIVE POWER   0 8 SHARED DISPOSITI